Speaker

Martin Steegmaier

Chief Scientific Officer, Molecular Partners

Martin Steegmaier, Chief Scientific Officer at Molecular Partners, is speaking at 8th Targeted Radiopharmaceuticals Summit Europe 2026 (London, United Kingdom, 1–3 Dec 2026) in the session “Target Selection Strategy Lab: What Makes a Winning Radiopharmaceutical Target?”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

8th Targeted Radiopharmaceuticals Summit Europe 2026
1–3 Dec 2026London, United Kingdom
- WorkshopTarget Selection Strategy Lab: What Makes a Winning Radiopharmaceutical Target?
- SpeakerBeyond Peptides: Advancing Radio-DARPin Therapeutics from Platform Innovation to Clinical Proof-of-Concept

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Martin Steegmaier, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].